Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Organ-on-a-Chip Conference

Uwe Marx's Biography



Uwe Marx, CSO & Founder, TissUse GmbH, Honorary Professor for Medical Biotechnology at the Technische Universität Berlin, Germany

Trained in human biology and medicine, Dr. Marx is an accomplished serial entrepreneur and the scientific founder of TissUse. He is a renowned tissue engineer and pioneered a human multi-organ-bioreactor program in the early 1990´s. Since 2010 he is the head of the “Multi-Organ-Chip” program in the Institute of Biotechnology at the Technische Universität Berlin, Germany. Over the course of his fruitful career in biotechnology, Dr. Marx has pursued ever more lifelike structures that can mimic human biology in vitro, culminating in the multi-organ-chip platform. Prior to founding TissUse, Dr. Marx was the scientific founder of the two successful Germany-based biotech companies, ProBioGen AG and VITA34, the first private umbilical cord blood bank in Europe.

Uwe Marx Image

A "Human-on-a-Chip" platform - Aiming for a Paradigm Shift in Substance Testing

Wednesday, 8 July 2015 at 14:30

Add to Calendar ▼2015-07-08 14:30:002015-07-08 15:30:00Europe/LondonA "Human-on-a-Chip" platform - Aiming for a Paradigm Shift in Substance TestingSELECTBIOenquiries@selectbiosciences.com

Strategies to develop “human-on-a-chip” platforms are applying micro-physiological systems towards the in vitro combination of miniaturized human organ equivalents into functional human mini-organisms, which aim to replace systemic toxicity testing and efficacy assessment of new drug candidates in animals. We have developed a universal multi-organ-chip platform for long-term culture of human 3D organ equivalents interconnected within a common capillary microfluidic network, mimicking physiological blood flow. A standard microscopic slide format has been selected for the microfluidic multi-organ-chips. The human organs are scaled down by a factor of 1:100000. Proof of concept combining miniaturized human liver and skin equivalents at steady culture conditions over 28 days was achieved. Subsequently, repeated dose substance test assays with co-cultures of human skin interconnected with dendritic cells and human liver in combination with neuronal spheroids have been qualified. Finally, in addition to the two organ-chip assays, a four-organ-chip combining human intestine, liver, skin and kidney equivalents into a functional ADMET test assay has been established.


Add to Calendar ▼2015-07-08 00:00:002015-07-09 00:00:00Europe/LondonOrgan-on-a-Chip ConferenceSELECTBIOenquiries@selectbiosciences.com